A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs

Clinical trial NCT02200380 · TERMINATED

Trial details

NCT number: NCT02200380
Sponsor: Celldex Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

For Donors Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling For Recipients Acute Myelogenous Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Myelodysplastic Syndrome (MDS)Chronic Myelogenous Leukemia (CML)Non-Hodgkins Lymphoma (NHL)Hodgkins Disease (HD)Chronic Lymphocytic Leukemia (CLL)

Start date: 2014-07-01
Primary completion: 2016-03-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.